STEP-HFpEF (Completed)
To evaluate the effect of semaglutide (GLP-1) in patients with obesity and chronic HFpEF on heart failure disease-specific symptoms, health status and quality of life, when compared with placebo
- Medicine
- Semaglutide
- Population
- Heart failure
- Phase
- III
- Starting year
- 2019